PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 9, 2025Scientific Reports3 citationsOpen Access

A machine learning model for predicting 28-day mortality in ICU patients with community-acquired pneumonia and acute kidney injury

View Full Paper
WJWenwen JiGWGuangdong WangTLTingting Liu

Key Points

  • To develop and validate machine learning models predicting 28-day mortality in ICU patients with community-acquired pneumonia and acute kidney injury.
  • Developed multiple machine learning survival models using MIMIC IV and MIMIC III databases.
  • Evaluated five models: Random Survival Forests, Gradient Boosting Machine, Lasso-Cox, CoxBoost, and Survival-SVM.
  • Performed internal and external validation of model predictive performance with AUC metrics.
  • Conducted decision curve analysis for clinical applicability.
  • Developed a web application for real-time mortality risk prediction.
  • CoxBoost model showed the highest predictive performance with an AUC of 0.737 in internal validation.
  • Achieved an AUC of 0.671 in the external validation cohort, outperforming established scoring systems.
  • Decision curve analysis indicated high net benefit over a range of predicted risks.
  • Key predictive features included hypertension and blood urea nitrogen.

Abstract

Acute kidney injury is a common and critical complication in patients with community-acquired pneumonia who are admitted to intensive care units, substantially increasing their risk of short-term mortality. To enhance early clinical decision-making, we developed and validated multiple machine learning-based survival models to predict 28-day mortality using data from the Medical Information Mart for Intensive Care (MIMIC IV and MIMIC III databases). Five models were evaluated: Random Survival Forests, Gradient Boosting Machine, Lasso-Cox, CoxBoost, and Survival-SVM. Among these, the CoxBoost model demonstrated superior predictive performance with an AUC of 0.737in internal validation cohort and an AUC of 0.671 in external validation cohort, outperforming established clinical scoring systems. Decision curve analysis indicated high net benefit across a clinically relevant range of predicted risks. Key predictive features identified by model interpretation included age, vasopressor use, NSAIDs use, hemoglobin level, hypertension, and blood urea nitrogen. To improve practical application, we developed a web application that allows for individualized, real-time mortality risk prediction at the bedside. This tool may help identify high-risk patients earlier and support timely, personalized treatment strategies in critical care environments.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ji et al. (2025) studied this question.

synapsesocial.com/papers/69401d622d562116f28f8f4bhttps://doi.org/10.1038/s41598-025-27236-x
Ask AI
Helpful
Bookmark
Share
View Full Paper